Troglitazone does not protect rat pancreatic β cells against free fatty acid-induced cytotoxicity

被引:38
作者
Cnop, M [1 ]
Hannaert, JC [1 ]
Pipeleers, DG [1 ]
机构
[1] Free Univ Brussels, Ctr Diabet Res, B-1090 Brussels, Belgium
关键词
pancreatic beta cells; islets of Langerhans; free fatty acids; lipotoxicity; thiazolidinediones; troglitazone; diabetes;
D O I
10.1016/S0006-2952(02)00860-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Thiazolidinediones are a novel class of antidiabetic drugs that reduce insulin resistance through interaction with nuclear peroxisome proliferator-activated receptor (PPAR)gamma. One of these agents, troglitazone, was also proposed to protect ss cells against FFA-induced toxicity, but this effect has not yet been directly demonstrated. We recently reported in vitro conditions under which free fatty acids (FFA) cause ss cell death by necrosis or apoptosis. The present study investigates whether troglitazone (10 muM) interferes with this FFA-induced toxicity. Addition of this compound did not protect against oleate- or palmitate-induced toxicity. On the contrary, it increased palmitate-induced necrosis during the first two days of culture, and elevated (increase by 10-20%, P < 0.05) both oleate-and palmitate-induced apoptosis after 8 days. These results do not support the view that troglitazone exerts a direct protective effect on ss cells that are exposed to cytotoxic FFA concentrations. They instead indicate that the agent may sensitize pancreatic ss cells to FFA-induced damage, raising the possibility that its use facilitates the deleterious effect of increased FFA levels on the pancreatic ss cell mass. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1281 / 1285
页数:5
相关论文
共 39 条
[1]   PPARγ, the ultimate thrifty gene [J].
Auwerx, J .
DIABETOLOGIA, 1999, 42 (09) :1033-1049
[2]   Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[3]   Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance [J].
Cavaghan, MK ;
Ehrmann, DA ;
Byrne, MM ;
Polonsky, KS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :530-537
[4]   Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion -: Mechanism of action [J].
Chan, CB ;
De Leo, D ;
Joseph, JW ;
McQuaid, TS ;
Ha, XF ;
Xu, F ;
Tsushima, RG ;
Pennefathner, PS ;
Salapatek, AMF ;
Wheeler, MB .
DIABETES, 2001, 50 (06) :1302-1310
[5]   Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation [J].
Cnop, M ;
Hannaert, JC ;
Hoorens, A ;
Eizirik, DL ;
Pipeleers, DG .
DIABETES, 2001, 50 (08) :1771-1777
[6]   Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells [J].
Dubois, M ;
Pattou, F ;
Kerr-Conte, J ;
Gmyr, V ;
Vandewalle, B ;
Desreumaux, P ;
Auwerx, J ;
Schoonjans, K ;
Lefebvre, J .
DIABETOLOGIA, 2000, 43 (09) :1165-1169
[7]   Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice [J].
Elstner, E ;
Müller, C ;
Koshizuka, K ;
Williamson, EA ;
Park, D ;
Asou, H ;
Shintaku, P ;
Said, JW ;
Heber, D ;
Koeffler, HP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8806-8811
[8]   Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects [J].
Ferrannini, E .
ENDOCRINE REVIEWS, 1998, 19 (04) :477-490
[9]   Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats [J].
Fulgencio, JP ;
Kohl, C ;
Girard, J ;
Pegorier, JP .
DIABETES, 1996, 45 (11) :1556-1562
[10]   The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity [J].
Gerich, JE .
ENDOCRINE REVIEWS, 1998, 19 (04) :491-503